Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for Oxygenation During One-Lung Ventilation
NCT03936140Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of iloprost in hypoxemia, sponsored by Seoul St. Mary's Hospital. Primary endpoint: Partial pressure of arterial oxygen. Started Jan 2018; status: completed.
02
Drugs
iloprost
03
Conditions
hypoxemia
Beyond the preview
Go deeper on NCT03936140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03936140.